Tranexamic acid and Icterus - a phase IV clinical study of FDA data

Summary:

Icterus is reported as a side effect among people who take Tranexamic acid (tranexamic acid), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Neupogen, and have Chronic myeloid leukaemia.

The phase IV clinical study analyzes which people have Icterus when taking Tranexamic acid. It is created by eHealthMe based on reports of 8,539 people who have side effects when taking Tranexamic acid from the FDA, and is updated regularly.

What is Tranexamic acid?

Tranexamic acid has active ingredients of tranexamic acid. It is often used in heavy or prolong menstrual bleeding. eHealthMe is studying from 8,687 Tranexamic acid users. Check the latest studies of Tranexamic acid.

What is Icterus?

Icterus (yellowish pigmentation of the skin) is found to be associated with 1,879 drugs and 3,033 conditions by eHealthMe. Check the latest studies of Icterus.

On Jun, 08, 2026

8,539 people reported to have side effects when taking Tranexamic acid.
Among them, 28 people (0.33%) have Icterus.

Among these 28 people:

How long have people been on Tranexamic acid when they have Icterus? *

What is the gender of people who have Icterus when taking Tranexamic acid? *

female: 64.29 %
male: 35.71 %

What is the age of people who have Icterus when taking Tranexamic acid? *

What are other drugs people take besides Tranexamic acid? *

What are other side effects people have besides Icterus? *

Fatigue (feeling of tiredness): 12 people, 42.86%
Fever: 11 people, 39.29%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 8 people, 28.57%
Thrombocytopenia (decrease of platelets in blood): 7 people, 25.00%
Liver Function Test Abnormal: 7 people, 25.00%
Aspartate Aminotransferase Increased: 6 people, 21.43%
Nausea (feeling of having an urge to vomit): 5 people, 17.86%
Acute Kidney Failure: 5 people, 17.86%
Alanine Aminotransferase Increased: 5 people, 17.86%
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets): 5 people, 17.86%

What are the existing conditions these people have? *

Vitreous Haemorrhage (intraocular (inside the eye) bleeding): 3 people, 10.71%
Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 3 people, 10.71%
Multiple Myeloma (cancer of the plasma cells): 2 people, 7.14%
Breakthrough Pain: 2 people, 7.14%
Candidiasis (candidiasis or thrush is a fungal infection): 2 people, 7.14%
Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 2 people, 7.14%
Hepatic Neoplasm Malignant (liver cancer): 2 people, 7.14%
Varices Oesophageal (enlarged and swollen veins at the bottom of the oesophagus, near the stomach): 2 people, 7.14%
Abdominal Pain: 2 people, 7.14%
Pneumonia: 2 people, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Tranexamic acid and have Icterus?

- Check whether Icterus is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Tranexamic acid:

Tranexamic acid (8,687 reports)

Icterus treatments and more:

Icterus (33,621 reports)

Browse all side effects of Tranexamic acid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Icterus:

Icterus (1,879 drugs)

Browse all the conditions that are associated with Icterus:

Icterus (3,033 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on tranexamic acid (the active ingredients of Tranexamic acid) and Tranexamic acid (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.